MedGenome, a genomics-driven research and diagnostics company, announced that it has acquired the Illumina Hiseq X Ten platform to fuel its research services capability and capacity.
MedGenome having presence in USA, India and Singapore, offers genomics solutions in cancer immunotherapy and diabetes and works with various commercial and academic researchers globally on genomic research projects.
The company is a market leader for genomic diagnostics in South Asia and a leading provider of genomics research services, globally.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.